US$ 23.19
glaucoma and semaglutide may cause blindness—US study warning adds to growing debate on rare side effect Ophthalmic complications observed in patients
Description
Subramanian and Rusch describe in a letter in Movement Disorders why weight loss in Parkinson's disease remains under-recognized and why monitoring nutrition should become a routine part of care

The GLP-1 NAION vision-loss MDL hit 146 cases on the July JPML report up 70% in two months as the GI-injury MDL heads to Rule 702 hearings September 10-18.

Amazon.com: GLP-1 Without The Hype: A no-nonsense guide to sorting facts, fear, side effects, and expectations (The Without the Hype Series): 9798243832656: Everheart, T.L., Busse, Teri: Books

Hims promises an easier start to online GLP-1 treatment
